Approval · Notice of Compliance 19533 · 2017
SUPRAX: Notice of Compliance 19533
Issued July 14, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19533
- Date
- July 14, 2017
- Company
- Odan Laboratories Ltd.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers